The data indicates a slight but consistent decline in liver malignant neoplasms mortality in Japan from 2024 to 2028, with standardized mortality rates per hundred thousand dropping from 10.2 to 9.5. Assuming stability in numbers, the average year-on-year decrease is approximately 1.8%. With no data provided for 2023, understanding recent historical trends remains speculative. While a steady decline, the compound annual growth rate (CAGR) over the five years is approximately -1.8%, suggesting persistent improvements in healthcare interventions or lifestyle factors.
Future trends to watch include advancements in medical technology, public health initiatives focusing on liver disease prevention, and potential impacts of healthcare policy changes in Japan. Continuous monitoring could help ensure sustained progress in reducing liver cancer mortality rates.
